BIODESIX, INC. Amortization of Debt Discount (Premium)
BIODESIX, INC. (BDSX) reported Amortization of Debt Discount (Premium) of $4.39 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2022-03-14
- BIODESIX, INC. amortization of debt discount (premium) for the quarter ending 2020-12-31 was $0.00.
- BIODESIX, INC. amortization of debt discount (premium) for the quarter ending 2020-09-30 was $1.78M.
- BIODESIX, INC. amortization of debt discount (premium) for the quarter ending 2020-06-30 was $1.93M.
- BIODESIX, INC. amortization of debt discount (premium) for the quarter ending 2020-03-31 was $677.00K.
- BIODESIX, INC. amortization of debt discount (premium) for fiscal 2020 was $4.39M, a 1575.19% increase from fiscal 2019.
- BIODESIX, INC. amortization of debt discount (premium) for fiscal 2019 was $262.00K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $1.78M derived: sum of 2 quarters · filed 2022-03-14 | $3.71M derived: sum of 3 quarters · filed 2022-03-14 | $4.39M 10-K · filed 2022-03-14 |
| 2020-09-30 | $1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $3.71M derived: sum of 2 quarters · filed 2021-11-15 | $4.39M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $2.61M 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $677.00K 10-Q · filed 2021-05-11 | |||
| 2019-12-31 | $262.00K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |